Real world prospective multi-centre study of Low-dose Abiraterone with meals in Indian patients.
Phase 2
- Conditions
- Health Condition 1: C61- Malignant neoplasm of prostate
- Registration Number
- CTRI/2021/07/034741
- Lead Sponsor
- Abhishek Pathak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Metastatic castrate sensitive prostate cancer
Metastatic castrate resistant prostate cancer
ECOG â?? PS 0,1,2,3,4
Exclusion Criteria
Severe coronary artery disease
Uncontrolled hypertension
Uncontrolled Diabetes mellitus
Metabolic disorders
Patients who received Bicalutamide for > 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method